Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Cardiac Valve Diseases and Treatments, Atrial Fibrillation Management and Outcomes, and Acute Myocardial Infarction Research.
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis
Large-bore mechanical thrombectomy vs standard of care for acute high-risk pulmonary embolism: Rationale and design of the PERSEVERE randomized controlled trial
Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial
PEERLESS II: A Randomized Controlled Trial of Large-Bore Thrombectomy Versus Anticoagulation in Intermediate-Risk Pulmonary Embolism
Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta‐Analysis
Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research Collaborative
Endovascular Ultrasound Renal Denervation to Treat Hypertension
Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study
Incidence of Mortality and Complications in High-Risk Pulmonary Embolism: A Systematic Review and Meta-Analysis
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations
Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program
Validating the Composite Pulmonary Embolism Shock Score for Predicting Normotensive Shock in Intermediate-Risk Pulmonary Embolism
Durable Left Ventricular Assist Device Outflow Graft Obstructions: Clinical Characteristics and Outcomes
Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19
SCAI Publications Committee Manual of Standard Operating Procedures: 2022 Update
Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
Initial Findings From the North American COVID-19 Myocardial Infarction Registry
Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Replacement
Mechanical Complications in ST-Elevation Myocardial Infarction (STEMI) Based on Different Reperfusion Strategies
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
Thrombosis in <scp>COVID</scp>‐19
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Considerations for cardiac catheterization laboratory procedures during the <scp>COVID</scp>‐19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (<scp><i>SCAI ELM</i></scp>) Members and Graduates
Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic
Impact of COVID‐19 pandemic on STEMI care: An expanded analysis from the United States
Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response Teams
Impact of the <i>CYP2C19*17</i> Allele on Outcomes in Patients Receiving Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications